openPR Logo
Press release

Global Peptic Ulcer Drugs Market with Prominent Players Takeda Pharmaceuticals Company Limited, Pfizer Inc. ETC till Insight 2022

05-21-2018 11:36 AM CET | Health & Medicine

Press release from: Market Reserach Future

Global Peptic Ulcer Drugs Market with Prominent Players Takeda

Global Peptic Ulcer Drugs Market Information, by Pharmacological class (proton pump inhibitors (PPIs), anti-histamines, H2 antagonists, antacids, antibiotics and others), by Clinical Application (gastric ulcers, duodenal ulcer, esophageal ulcer) - Forecast Till 2022

KEY PLAYERS FOR PEPTIC ULCER DRUGS MARKET

Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc. Helicure AB and Eumedica Pharmaceuticals

The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2445 .

MARKET SCENARIO FOR PEPTIC ULCER DRUGS MARKET

Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer.

The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics.

SEGMENTS FOR PEPTIC ULCER DRUGS MARKET

Global peptic ulcer drugs market has been segmented on the basis of pharmacological class (proton pump inhibitors (PPIs), anti-histamines, H2 antagonists, antacids, antibiotics and others), by clinical application (gastric ulcers, duodenal ulcer, esophageal ulcer) and region.

REGIONAL ANALYSIS FOR PEPTIC ULCER DRUGS MARKET

Globally North America is the largest market of global peptic ulcer drugs. Europe is the second largest market for global peptic ulcer drugs. Soon the market of peptic ulcer drugs will be dominated by developing regions particularly Asia Pacific which will be the fastest growing region.

Get Discount @ https://www.marketresearchfuture.com/check-discount/2445 .

MAJOR TOC FOR PEPTIC ULCER DRUGS MARKET

CHAPTER 1. INTRODUCTION

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

CHAPTER 2. RESEARCH METHODOLOGY

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

CHAPTER 3. MARKET DYNAMICS

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

CHAPTER 4. MARKET FACTOR ANALYSIS

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power of Suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity Of Competitor’s

4.1.4 Threat of New Entrants

CHAPTER 5. GLOBAL PEPTIC ULCER DRUGS MARKET, BY PHARMACOLOGICAL CLASS

5.1 Introduction

5.1.2 Proton Pump Inhibitors (PPIs)

5.1.3 Anti-Histamines

5.1.4 H2 Antagonists

5.1.5 Antacids

5.1.6 Antibiotics

5.1.7 Others

LIST OF TABLES

TABLE 1 GLOBAL PEPTIC ULCER DRUGS MARKET, 2013-2022 (USD MILLION)

TABLE 2 GLOBAL PEPTIC ULCER DRUGS MARKET, BY PHARMACOLOGICAL CLASS 2013-2022 (USD MILLION)

TABLE 3 GLOBAL PEPTIC ULCER DRUGS MARKET, BY CLINICAL APPLICATION, 2013-2022 (USD MILLION)

TABLE 4 GLOBAL PEPTIC ULCER DRUGS MARKET, BY REGION, 2013-2022 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL PEPTIC ULCER DRUGS MARKET, BY PHARMACOLOGICAL CLASS

FIGURE 4 GLOBAL PEPTIC ULCER DRUGS MARKET, BY CLINICAL APPLICATION

FIGURE 5 GLOBAL PEPTIC ULCER DRUGS MARKET, BY REGION

FIGURE 6 GLOBAL PEPTIC ULCER DRUGS MARKET: COMPANY SHARE ANALYSIS, 2015 (%)

TOC CONTINUED…

Ask to Expert Inquire @ https://www.marketresearchfuture.com/enquiry/2445 .

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptic Ulcer Drugs Market with Prominent Players Takeda Pharmaceuticals Company Limited, Pfizer Inc. ETC till Insight 2022 here

News-ID: 1056288 • Views:

More Releases from Market Reserach Future

Pharma Social Media Market Set to Grow at an Impressive CAGR of 9.72% Through 2034 | 13.23 (USD Billion)
Pharma Social Media Market Set to Grow at an Impressive CAGR of 9.72% Through 20 …
Pharma Social Media Market: Transforming Healthcare Communication The Pharma Social Media Market has emerged as a vital tool in the healthcare industry, bridging the gap between pharmaceutical companies and patients, healthcare professionals, and stakeholders. With the rise of digital platforms, pharmaceutical organizations are increasingly utilizing social media to enhance engagement, disseminate information, and build trust among their audience. The market's evolution is deeply influenced by research, trends, and developments that drive
India Ophthalmic Drugs Market Projected to Reach 7.5 (USD Billion), with a Robust 10.503% CAGR Till 2035
India Ophthalmic Drugs Market Projected to Reach 7.5 (USD Billion), with a Robus …
India's Ophthalmic Drugs: Advancing Eye Care for a Healthier Future Eye health plays a crucial role in maintaining overall well-being, and India's ophthalmic drug sector has steadily progressed to meet the needs of its vast and diverse population. With increasing awareness about eye disorders and the importance of regular eye care, the availability and accessibility of effective medicines have become an essential part of healthcare services across the country. Request To Free
Fibrotic Diseases Treatment Market is Projected to Reach USD 28.2 Billion, with a Robust 5.71% CAGR Till 2032
Fibrotic Diseases Treatment Market is Projected to Reach USD 28.2 Billion, with …
Market Overview The Fibrotic Diseases Treatment Market is witnessing significant expansion as healthcare providers globally focus on the development and adoption of innovative therapies for fibrotic conditions. Fibrosis is a pathological condition characterized by the excessive accumulation of scar tissue in various organs, including the lungs, liver, kidneys, heart, and skin. Left untreated, fibrosis can impair organ functionality, lead to chronic complications, and significantly reduce quality of life. Fibrotic Diseases Treatment Market
Vonoprazan Fumarate API Market Expected to Hit USD 4.83 Billion by 2034 with a Remarkable 14.51% CAGR
Vonoprazan Fumarate API Market Expected to Hit USD 4.83 Billion by 2034 with a R …
Market Overview The Vonoprazan Fumarate API Market is gaining significant traction as healthcare providers and pharmaceutical companies worldwide focus on innovative therapies for gastrointestinal disorders. Vonoprazan, a novel potassium-competitive acid blocker (P-CAB), has become a game-changer in the management of gastroesophageal reflux disease (GERD), gastric ulcers, and erosive esophagitis. Its rapid action and prolonged duration of effect offer a promising alternative to traditional proton pump inhibitors (PPIs), which often take longer

All 5 Releases


More Releases for PEPTIC

Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,
Peptic Ulcer Market New Product Development & Latest Trends
Introduction Peptic ulcers are open sores that develop on the inner lining of the stomach and the upper portion of the small intestine. They are primarily caused by Helicobacter pylori (H. pylori) infection, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), smoking, alcohol consumption, and stress-related factors. Symptoms include abdominal pain, bloating, indigestion, and, in severe cases, gastrointestinal bleeding or perforation. Despite improved therapeutic options, peptic ulcers remain a major healthcare concern worldwide
Evolving Market Trends In The Peptic Ulcer Industry: Advancements In Peptic Ulce …
The Peptic Ulcer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Peptic Ulcer Market Size During the Forecast Period? In recent times, there has been a consistent expansion in the peptic ulcer market size. It is projected to escalate from $4.1 billion
Key Influencer in the Peptic Ulcer Market 2025: Obesity Fuels The Expansion Of T …
What Is the Forecasted Market Size and Growth Rate for the Peptic Ulcer Market? The peptic ulcer market has grown steadily in recent years. It will rise from $4.1 billion in 2024 to $4.24 billion in 2025, at a CAGR of 3.5%. This growth is attributed to the rising prevalence of Helicobacter pylori infection, increased use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns, and a focus
Peptic Ulcer Drugs Market - Relief Within Reach: Transforming Treatment for Pept …
Newark, New Castle, USA - new report, titled Peptic Ulcer Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peptic Ulcer Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peptic Ulcer Drugs market. The report offers an overview of
Peptic Ulcer Market Shares, Strategies, and Forecasts Analysis
Sores that develop on the lining of stomach, esophagus, and intestines are called peptic ulcers. Symptoms of peptic ulcers include vomiting, burning stomach pain, bloating, and food intolerance. These can be of three types: gastric ulcers, duodenal ulcers, and esophageal ulcers. Some of the causes of peptic ulcers are stomach infections caused by H. pylori, alcoholism, stomach cancers, usage of anti-inflammatory drugs such as aspirin, and smoking. Peptic ulcers, if